Bonfiglio John N Insider Trades

Insider Trading History

Track insider trading activity for Bonfiglio John N. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Genprex
Genprex GNPX
Director
Holding Value $0 0 shares
Last Trade
Feb 12, 2019 Sale
$66.7k 45,976 shares
$1.45
$0.70
Marker Therapeutics
Marker Therapeutics MRKR
President And COO
Holding Value $38.3k 26,054 shares
Last Trade
Mar 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22k 5,220 shares
$4.22
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
President And COO
Holding Value $30.6k 20,834 shares
Last Trade
Dec 12, 2016 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$51.5k 10,417 shares
$4.94
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
President And COO
Holding Value $45.9k 31,251 shares
Last Trade
Dec 12, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.5k 10,417 shares
$4.94
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
President And COO
Holding Value $15.3k 10,417 shares
Last Trade
Dec 12, 2016 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$51.5k 10,417 shares
$4.94
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
President And COO
Holding Value $126k 85,416 shares
Last Trade
Dec 12, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.5k 10,417 shares
$4.94
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
See Remarks
Holding Value $1.69M 1,150,000 shares
Last Trade
Jul 18, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.25M 750,000 shares
$1.67
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
See Remarks
Holding Value $368k 250,000 shares
Last Trade
Jul 15, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 250,000 shares
$1.67
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
Director
Holding Value $588k 400,000 shares
Last Trade
Jul 23, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 150,000 shares
$1.67
$1.47
Marker Therapeutics
Marker Therapeutics MRKR
Director
Holding Value $0 0 shares
Last Trade
Jul 23, 2015 Sale
$417k 250,000 shares
$1.67
$1.47
Ambipar Emergency Response
Ambipar Emergency Response AMBI
Director
Holding Value $0 0 shares
Last Trade
Dec 31, 2014 Sale
No data
No data
$0.44
Oragenics
Oragenics OGEN
President And CEO
Holding Value $232k 385,255 shares
Last Trade
Aug 13, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1M 1,000 shares
$1,002.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $267k 444,255 shares
Last Trade
Nov 27, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$314M 174,533 shares
$1,800.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $231k 384,255 shares
Last Trade
Nov 27, 2013 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$108M 60,000 shares
$1,800.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $162k 269,722 shares
Last Trade
Oct 18, 2013 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$89.7M 50,000 shares
$1,794.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $192k 319,722 shares
Last Trade
Oct 18, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$271M 150,843 shares
$1,794.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $110k 183,818 shares
Last Trade
Oct 23, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2M 56,482 shares
$1,260.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $101k 168,879 shares
Last Trade
Oct 23, 2012 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.8M 14,939 shares
$1,260.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $76.5k 127,336 shares
Last Trade
Aug 06, 2012 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$57.6M 34,914 shares
$1,650.00
$0.60
Oragenics
Oragenics OGEN
President And CEO
Holding Value $97.5k 162,250 shares
Last Trade
Aug 06, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218M 132,000 shares
$1,650.00
$0.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up